Where is Beam headquartered?

Beam is located in Cambridge, MA.

Who invested in Beam?

Beam has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Beam?

Beam closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

beamtx.com

Beam

Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.

Business Model:

Revenue: $92M

Employees: 201-500

Geographic Data

Address: 26 Landsdowne Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$260M

Raised Total:

$689M

Social

Twitter

Crunchbase

Metrics

1,240,005Website Global Rank

24,032Website Monthly Traffic

Twitter Followers

Description

Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.

Contact Phone:
+18573278775

Contact Email:

IPO Details

Beam went public on 2/5/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/5/2020

IPO Valuation:
$843M

Ticker Symbol:
BEAM

IPO Price:
$17/share

Amount Raised:
$178M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2018	Series A		$87M	F-Prime Capital Partners ARCH Venture Partners Editas Medicine
10/2020	Post-IPO Equity		$117.5M
11/2018	Series B		$135M	Redmile Group, LLC Google Ventures Altitude Life Science Ventures F-Prime Capital ARCH Venture Partners Eight Roads Ventures Omega Funds
5/2018	Series A	3	$87M	ARCH Venture Partners F-Prime Capital OUP (Osage University Partners) ARCH Venture Partners F-Prime Capital
1/2021	Post-IPO Equity	5	$260M	Perceptive Advisors Casdin Capital Farallon Capital Management Redmile Group Cormorant Asset Management Perceptive Advisors Casdin Capital Farallon Capital Management Redmile Group Cormorant Asset Management
2/2020	Post-IPO Equity		$207M
3/2019	Series B	8	$135M	F-Prime Capital ARCH Venture Partners Cormorant Asset Management Redmile Group Altitude Life Science Ventures Omega Funds GV Eight Roads Ventures F-Prime Capital ARCH Venture Partners Cormorant Asset Management Redmile Group Altitude Life Science Ventures

Acquisitions

Announced Date	Name	Price
2/2021	Guide Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details